Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-group boceprevir access study in genotype 1 chronic hepatitis C prior nonresponders
2008-004556-71Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of boceprevir in hepatitis C virus infection, sponsored by Merck & Co. Started Mar 2009; status: completed.
02
Drugs
boceprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2008-004556-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004556-71.